Guardian Capital Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $15.4M | Buy |
|
|||||
2024
Q2 | $18.5M | Sell |
|
|||||
2024
Q1 | $17.5M | Sell |
|
|||||
2023
Q4 | $16.1M | Sell |
|
|||||
2023
Q3 | $16.5M | Sell |
|
|||||
2023
Q2 | $13.2M | Sell |
|
|||||
2023
Q1 | $16.8M | Sell |
|
|||||
2022
Q4 | $14.5M | Sell |
|
|||||
2022
Q3 | $11.4M | Sell |
|
|||||
2022
Q2 | $12.5M | Sell |
|
|||||
2022
Q1 | $13.6M | Buy |
|
|||||
2021
Q4 | $11.6M | Sell |
|
|||||
2021
Q3 | $11.6M | Sell |
|
|||||
2021
Q2 | $10.2M | Buy |
|
|||||
2021
Q1 | $8.28M | Buy |
|
|||||
2020
Q4 | $8.05M | Buy |
|
|||||
2020
Q3 | $7.97M | Sell |
|
|||||
2020
Q2 | $5.34M | Buy |
|
|||||
2020
Q1 | $4.42M | Buy |
|
|||||
2019
Q4 | $6.23M | Buy |
|
|||||
2019
Q3 | $5M | Buy |
|
|||||
2019
Q2 | $4.94M | Buy |
|
|||||
2019
Q1 | $4.44M | Buy |
|
|||||
2018
Q4 | $3.88M | Buy |
|
|||||
2018
Q3 | $3.44M | Buy |
|
|||||
2018
Q2 | $3.95M | Buy |
|
|||||
2018
Q1 | $3.62M | Buy |
|
|||||
2017
Q4 | $4.2M | Buy |
|
|||||
2017
Q3 | $3.64M | Buy |
|
|||||
2017
Q2 | $2.99M | Buy |
|
|||||
2017
Q1 | $2.33M | Sell |
|
|||||
2016
Q4 | $2.55M | Buy |
|
|||||
2016
Q3 | $2.63M | Sell |
|
|||||
2016
Q2 | $3.46M | Buy |
|
|||||
2016
Q1 | $3.32M | Buy |
|
|||||
2015
Q4 | $3.31M | Buy |
|
|||||
2015
Q3 | $2.95M | Buy |
|
|||||
2015
Q2 | $3.15M | Buy |
|
|||||
2015
Q1 | $3.59M | Buy |
|
|||||
2014
Q4 | $2.35M | Buy |
|
|||||
2014
Q3 | $2.25M | Buy |
|
|||||
2014
Q2 | $1.92M | Buy |
|
|||||
2014
Q1 | $1.84M | Sell |
|
|||||
2013
Q4 | $1.79M | Buy |
|
|||||
2013
Q3 | $1.3M | Buy |
|